Stock RVNC REVANCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Revance Therapeutics, Inc.

Equities

RVNC

US7613301099

Market Closed - Nasdaq
Other stock markets
 21:00:00 22/05/2024 BST 		5-day change 1st Jan Change
2.92 USD -2.99% Intraday chart for Revance Therapeutics, Inc. -11.78% -66.78%
05-10 Needham Adjusts Price Target on Revance Therapeutics to $12 From $18, Maintains Buy Rating MT
05-10 Piper Sandler Cuts Price Target on Revance Therapeutics to $11 From $20, Maintains Overweight Rating MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
REVANCE THERAPEUTICS, INC.
Biopharmaceuticals
-2.99%-11.78%-66.78%-91.02%-75.44% 314M
Bearish
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. RVNC Stock
  4. Charts Revance Therapeutics, Inc.
  5. Relative Strength Chart